Morrow; Matthew P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Morrow; Matthew P..The latest application filed is for "compositions, comprising improved il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same".

Company Profile

3.14.18

Morrow; Matthew P. - Bala Cynwyd PA
Morrow; Matthew P - Philadelphia PA US
Morrow; Matthew P - Bala Cynwyd PA
Morrow; Matthew P. - Philadelphia PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions, Comprising Improved Il-12 Genetic Constructs And Vaccines, Immunotherapeutics And Methods Of Using The Same App 20220193230 - Weiner; David ; et al.	2022-06-23
Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same Grant 11,241,496 - Weiner , et al. February 8, 2	2022-02-08
Vaccines Having An Antigen And Interleukin-21 As An Adjuvant App 20210236631 - Weiner; David B. ; et al.	2021-08-05
Vaccines having an antigen and interleukin-21 as an adjuvant Grant 11,007,265 - Weiner , et al. May 18, 2	2021-05-18
Proteins comprising MRSA Pbp2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat MRSA infections Grant 10,980,870 - Weiner , et al. April 20, 2	2021-04-20
Influenza nucleic acid molecules and vaccines therefrom Grant 10,363,302 - Weiner , et al.	2019-07-30
Vaccines Having an Antigen and Interleukin-21 As An Adjuvant App 20190060447 - Weiner; David B. ; et al.	2019-02-28
Proteins Comprising MRSA Pbp2a and Fragments Thereof, Nucleic Acids Encoding the Same, and Compositions and Their Use to Prevent and Treat MRSA Infections App 20190030155 - Weiner; David B. ; et al.	2019-01-31
Vaccines having an antigen and interleukin-21 as an adjuvant Grant 10,166,288 - Weiner , et al. J	2019-01-01
Compositions, Comprising Improved Il-12 Genetic Constructs And Vaccines, Immunotherapeutics And Methods Of Using The Same App 20180333485 - Weiner; David ; et al.	2018-11-22
Vaccines and immunotherapeutics using IL-28 and compositions and methods of using the same Grant 10,071,154 - Weiner , et al. September 11, 2	2018-09-11
Proteins comprising MRSA PBP2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat MRSA infections Grant 10,064,931 - Weiner , et al. September 4, 2	2018-09-04
Compositions, comprising improved Il-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same Grant 9,981,036 - Weiner , et al. May 29, 2	2018-05-29
Influenza Nucleic Acid Molecules and Vaccines Therefrom App 20180133307 - Weiner; David B. ; et al.	2018-05-17
Influenza nucleic acid molecules and vaccines made therefrom Grant 9,884,106 - Weiner , et al. February 6, 2	2018-02-06
Proteins Comprising Mrsa Pbp2a And Fragments Thereof, Nucleic Acids Encoding The Same, And Compositions And Their Use To Prevent And Treat Mrsa Infections App 20180028640 - Weiner; David B. ; et al.	2018-02-01
Proteins comprising MRSA PBP2a and fragments thereof, nucleic acids encoding the same, and compositions and their use to prevent and treat MRSA infections Grant 9,750,795 - Weiner , et al. September 5, 2	2017-09-05
Vaccines Having an Antigen and Interleukin-21 As An Adjuvant App 20170232100 - Weiner; David B. ; et al.	2017-08-17
Compositions, Comprising Improved Il-12 Genetic Constructs And Vaccines, Immunotherapeutics And Methods Of Using The Same App 20160235840 - Weiner; David B. ; et al.	2016-08-18
Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same Grant 9,272,024 - Weiner , et al. March 1, 2	2016-03-01
Influenza Nucleic Acid Molecules And Vaccines Made Therefrom App 20160030548 - Weiner; David B. ; et al.	2016-02-04
Influenza nucleic acid molecules and vaccines made therefrom Grant 9,192,660 - Weiner , et al. November 24, 2	2015-11-24
Compositions, Comprising Improved Il-12 Genetic Constructs And Vaccines, Immunotherapeutics And Methods Of Using The Same App 20150004188 - Weiner; David B. ; et al.	2015-01-01
Proteins Comprising Mrsa Pbp2a And Fragments Thereof, Nucleic Acids Encoding The Same, And Compositions And Their Use To Prevent And Treat Mrsa Infections App 20140341944 - Weiner; David B. ; et al.	2014-11-20
Influenza Nucleic Acid Molecules And Vaccines Made Therefrom App 20130052222 - Weiner; David B ; et al.	2013-02-28
Influenza nucleic acid molecules and vaccines made therefrom Grant 8,298,820 - Weiner , et al. October 30, 2	2012-10-30
Influenza Nucleic Acid Molecules And Vaccines Made Therefrom App 20120064116 - Weiner; David B. ; et al.	2012-03-15
Influenza Nucleic Acid Molecules And Vaccines Made Therefrom App 20110182938 - Weiner; David B. ; et al.	2011-07-28
Nucleic Acid Molecule Encoding Consensus Influenza A Hemagglutinin H1 App 20110184160 - Weiner; David B. ; et al.	2011-07-28
Vaccines And Immunotherapeutics Using Il-28 And Compositions And Methods Of Using The Same App 20110104105 - Weiner; David B ; et al.	2011-05-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.